Wanda, in partnership with Dignity Health, announced today the launch of the OncoVerse™ virtual care collaboration platform.

OncoVerse is a digital health platform designed to enable the patient’s care team to collaborate in real-time and allow clinicians across all disciplines to work together to determine the most effective treatment plan for cancer patients.

"We are thrilled to partner with Dignity Health to launch the OncoVerse product," said Steve Curd, CEO of Wanda.

"OncoVerse will streamline and support the decision making processes of Dignity Health’s physicians and other supporting health care professionals by ensuring that the entire care team has the right information at the right time, which reinforces the power of personalized medicine. As cancer therapies continue to advance, facilitating individualized cancer decision support is well-aligned with Wanda’s mission: improving the efficiency and effectiveness of the management of chronic conditions."

OncoVerse was initially conceived by a Dignity Health physician who wanted a tool to improve team collaboration, especially when evaluating a complex cancer case and determining the appropriate treatment plan. Dignity Health engaged Wanda to develop the software due to the company’s proven track record to support informed treatment decisions, and to reduce administrative costs.

"Dignity Health is committed to developing partnerships that harness the tremendous potential of technology to help providers and patients make better day-to-day decisions about care," said Costanzo DiPerna, MD, Medical Director for the Dignity Health Cancer Institute of the Greater Sacramento Region and Chief of Thoracic Surgery. "We are excited to work with Wanda and deliver on our vision to provide the highest quality patient care."

OncoVerse enables unprecedented information-sharing capabilities through geographically dispersed, structured collaboration of the multidisciplinary care team in real-time. Dignity Health can now expand the reach of its best available clinical decision-making support through OncoVerse to rural and remote areas, enabling patients in those locations to benefit from insights previously only shared at large medical centers.

Wanda and Dignity Health intend to jointly market the Oncoverse platform available to other oncology programs across the U.S. later in 2016.